Therefore, a monoclonal antibody that recognizes a specific region of NMP22 can be used to detect the mitogen protein released by bladder tumor cells in urine to determine whether there is bladder cancer [14]. This evidence concerns the gene NUMA1 and urinary bladder cancer.